LATEST NEWS
Special notice: For important updates about COVID-19 and its impact on CNSI facilities, please visit our Coronavirus guidance page.
June 22, 2020 | New technique allows scientists to measure mitochondrial respiration in frozen tissue
Scientists led by Dr. Orian Shirihai, director of the metabolism theme at the David Geffen School of Medicine at UCLA, have developed a method for restoring oxygen-consumption activity to previously frozen mitochondria samples, even years after they have been...
June 17, 2020 | Adhesive film turns smartwatch into biochemical health monitoring system
UCLA engineers have designed a thin adhesive film that could upgrade a consumer smartwatch into a powerful health monitoring system. The system looks for chemical indicators found in sweat to give a real-time snapshot of what’s happening inside the body.June 17, 2020...
June 1, 2020 | Coronavirus vaccine development underway by Vault Pharma
An emerging company developing biotechnology invented at UCLA is adapting their approach to address the novel coronavirus, with the goal of adding to the anti-COVID-19 arsenal that follows an initial vaccine. The company, Vault Pharma, is working with UCLA and other...
May 29, 2020 | Large Droplet-Sorting Now Possible at High Speeds
Bioengineers from UCLA and University of Tokyo have significantly increased the speed at which large liquid droplets, potentially containing individual live cells, can be sorted intact and in bulk.May 29, 2020 | Large Droplet-Sorting Now Possible at High Speeds ...
May 22, 2020 | Deep learning-based screening of sickle cell disease using a mobile microscope
The strong need for improved access to testing led us to develop an automated method to diagnose SCD using images of a blood smear captured using a cost-effective mobile microscope.May 22, 2020 | Deep learning-based screening of sickle cell disease using a mobile...
May 4, 2020 | Myst Therapeutics Appoints George Smith as Vice President of Business Operations
Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell (PuriT™) therapy products for cancer, announced the appointment of George Smith, PhD, MBA as Vice President of Business Operations.May...
April 27, 2020 | A step toward a more efficient way to make gene therapies to attack cancer, genetic disorders
A UCLA-led research team today reports that it has developed a new method for delivering DNA into stem cells and immune cells safely, rapidly and economically. April 27, 2020 | A step toward a more efficient way to make gene therapies to attack cancer, genetic...
April 17, 2020 | Mathematics professors earn NSF grant to calculate COVID-19 transmission rates
UCLA mathematics professors Andrea Bertozzi and Mason Porter will use mathematical modeling, incorporating the specific features of COVID-19, to provide insights to those who are developing strategies to mitigate the spread of the disease.Mathematics professors earn...
April 15, 2020 | Researchers reveal the mechanisms behind a natural bacteria killer
Scientists are one step closer to adapting the bacteria-killing power of a naturally occurring nanomachine, a tiny particle that performs a mechanical action.April 15, 2020 | Researchers reveal the mechanisms behind a natural bacteria killer Findings by UCLA-led team...